Drug major Sun Pharmaceutical Industries on Saturday reported a 46.02% fall in its net consolidated profit year-on-year to ₹1,107 crore for the quarter ended September. Consolidated net sales of the company stood at ₹6,803.31 crore in the reporting period as against ₹7,979.31 crore a year ago. The results were "impacted by lower sales growth, volatile currency movements and supply constraints”.